U.S. Dialysis Market size to exceed $52.5bn by 2028

Dialysis Market size is set to surpass USD 52.5 billion by 2028, according to a new research report by Global Market Insights Inc.
 

The wide availability of dialysis products and services will accelerate the business expansion. Key market players of the U.S. dialysis industry such as Fresenius and DaVita are focused on improving patient health through dialysis services. Such scenarios will boost the market demand.
 

Rising incidences of diabetes will propel the industry landscape

Increasing incidence of diabetes in several states of the U.S. including West Virginia, Mississippi, Alabama, South Carolina, and others owing to sedentary lifestyle will ultimately upsurge the demand for dialysis treatment. Diabetes hinders with regular kidney functioning and frequently results in kidney failure that augments the demand for dialysis treatment. Growing prevalence of diabetes in the U.S. is attributed to various factors including obesity, lack of physical activity, changes in diet, aging population, and others.
 

Increasing demand for peritoneal dialysis treatment will fuel the overall market expansion

U.S. dialysis market from peritoneal dialysis segment is expected to witness 7% CAGR from 2022 to 2028. Increasing demand for peritoneal dialysis due to technological advances in the equipment used during the procedure will impel the segment revenue. In addition, peritoneal dialysis has several advantages over hemodialysis, such as there are few dietary restrictions, lifestyle flexibility, and patients do not have to go to the hospital on a regular basis. These factors are expected to further drive market development.
 

Browse key industry insights spreads across 330 pages with 770 market data tables & 15 figures & charts from the report,” U.S. Dialysis Market Analysis By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service (Equipment {Dialysis Machines, Water Treatment Systems}, Consumables {Dialyzers, Catheters, Access Products, Concentrates}, Services {Acute Dialysis, Chronic Dialysis), By End-use (In-center Dialysis, Home Dialysis), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/us-dialysis-market
 

New product launches will foster the market outlook

U.S. dialysis market from equipment segment accounted for around 7.6% revenue share in 2021. Equipment segment is further divided into dialysis machines, water treatment systems and others. Demand for dialysis equipment has increased owing to surging demand for continuous renal replacement therapy (CRRT). This therapy involves dialysis equipment with a dialyzer and a special filter that continuously cleans the patient’s blood for an extended period of time, and unlike conventional machines these are used three times a week. Also, new equipment launches will ensure profitable scenario for dialysis industry. Furthermore, U.S. regulators have indicated Carpediem system for use in patients with acute kidney injury or fluid excess requiring hemodialysis or hemofiltration therapy. Thus, such positive scenarios will prove beneficial for the segment progression.
 

Rising preference for in-center dialysis facilities will enhance the industry size

U.S. dialysis market in-center dialysis segment exceeded USD 28.7 billion in 2021. Demand for in-center dialysis is high as most of the dialysis patient prefer hemodialysis. For instance, according to Kidney Project by University of California and San Francisco, 90% of all dialysis patient in the U.S. prefer hemodialysis since people are more aware of it. Also, research have shown that hemodialysis (HD) has a higher dialysis efficacy and has better capacity control. This will increase its adoption during forecast timeframe.
 

Cost effectiveness of dialysis service in Michigan will augment the industry scenario

Michigan Dialysis Market is projected to exhibit 6% CAGR during the projected timeline owing to the presence of numerous dialysis centers and favorable reimbursement policies in states such as Illinois, Michigan, and Ohio. For instance, according to the National Kidney Foundation in Michigan, the federal government pays 80% of all dialysis costs for most patients. Additionally, companies are also developing advanced technologies through huge R&D investments. Such positive scenario proves to be beneficial for regional market statistics.
 

Industry players are implementing various market growth strategies to improve their market position

Some of the eminent market players operating in the U.S. dialysis industry include Asahi Kasei Corporation, Baxter International, Becton Dickinson, B. Braun, Dialysis Care Center, DaVita Inc., Rockwell Medical Inc., Fresenius Medical Care, Medtronic, Rogosin Institute, Nipro Corporation, Sanderling Renal Services, Toray Industries Inc., Satellite Healthcare, and U.S. Renal Care. Market leaders are focusing on strategic partnerships and agreements to launch novel products to gain a competitive advantage in the industry.
 

For instance, in February 2021, Rockwell Medical announced the availability of Triferic AVNU (ferric pyrophosphate citrate injection) for replacement of iron and maintenance of hemoglobin in patients on hemodialysis in the U.S. This strategy enhanced the company’s business revenue.